SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 54.19-4.7%Jan 15 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (2171)11/30/2000 2:15:55 PM
From: aknahow  Read Replies (1) of 52153
 
I agree that mandatory reporting would not rlead the FDA to loosen up on approvals give the present structure and concepts of protection in place.

Eventually things may change. Mandatory reporting, for a limited time of one or even two years, might help others including the public be more willing to seek change. Right now I can pay as much as I want for any natural product to cure whatever I think it will. However, I am prevented from using a product produced by a drug company, that a doctor might think would be of use, until the government gives its' approval.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News